Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients

Affiliations

• ¹ Department of Microbiology, and Immunology and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, 621 Rubin Building-HB7936, 1 Medical Center Drive, Lebanon, NH, 03756, USA. hugo.ariaspulido@dartmouth.edu.
• ² Departments of Pathology and Oncology, The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
• ³ Department of Pathology, Centre Pierre et Marie Curie, EHS Salim Zemirli et Faculté de Médecine d'Alger, Université Alger 1, Algiers, Algeria.
• ⁴ Department of Mathematics and Statistics, University of New Mexico, Albuquerque, NM, USA.
• ⁵ Department of Pathology, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
• ⁶ Department of Pathology, AZ Turnhout/UZ, Leuven, Belgium.
• ⁷ Department of Pathology and Laboratory Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
• ⁸ Department of Medical Oncology, and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
• ⁹ Department of Microbiology, and Immunology and Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, 621 Rubin Building-HB7936, 1 Medical Center Drive, Lebanon, NH, 03756, USA.
• ¹⁰ Biomedical Sciences Graduate Training Program, University of California, San Francisco, CA, 94143, USA.
• ¹¹ Division of Molecular Medicine, Department of Internal Medicine, Autophagy, Inflammation and Metabolism Center of Biomedical Research Excellence, University of New Mexico Comprehensive Cancer Center, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
• ¹² University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA, USA.